Homologous recombination repair (HRR) alterations may be passenger events in patients with advanced prostate cancer (PC) with high tumor mutational burden (hTMB). Journal of Clinical Oncology 2024;42(4):206-206
Date
01/01/2024DOI
10.1200/JCO.2024.42.4_suppl.206Scopus ID
2-s2.0-105024484473 (requires institutional sign-in at Scopus site) 1 CitationAuthor List
Bhatlapenumarthi V, De Sarkar N, Patwari A, Antonarakis ES, Nelson AA, Kilari DAuthors
Navonil De Sarkar PhD Assistant Professor in the Pathology and Laboratory Medicine department at Medical College of WisconsinDeepak Kilari MD Associate Professor in the Medicine department at Medical College of Wisconsin









